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ABSTRACT
Connective tissue-type mast cells degranulate in res-
ponse to a neurogenic peptide, substance P, whereas
bone marrow-derived mast cells (BMMC) do not
respond to this stimulant when prepared with a
combination of interleukin-3 and interleukin-4. In the
present study we demonstrated that BMMC obtained
from three different strains of mice, NC, BALB/c and
C57BL/6, which are immature mast cells low in
histamine content and unresponsive to substance P,
increased 10 to 100-fold in their histamine content
and acquired responsiveness to substance P after co-
culture with NIH/3T3 fibroblasts in the presence of
10 ng/mL of stem cell factor (SCF). This change was
observed after 1 week of co-culture and increased
over a 3 week period, whereas 3T3 fibroblasts or SCF
(100 ng/mL) alone was insufficient to duplicate this
phenotypic change in BMMC. It is suggested that the
response to substance P of mast cells is not through
NK- 1 receptors but rather through a different mecha-
nism, since the reverse transcriptase-mediated poly-
merase chain reaction technique failed to show
expression of NK- 1 receptor mRNA in BMMC after co-
culture as well as before co-culture.
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INTRODUCTION
Mast cells originate from hematopoietic cells located in
bone marrow. Precursors of mast cells circulate in the
blood, reach tissues, and then differentiate depending on
the micro-environment of the tissue. Mouse mast cells
that reside in serosal cavities and skin, connective tissue-
type mast cells (CTMC), differ in a number of ways with
respect to phenotype from mouse mast cells that reside in
mucosa of the intestine, mucosal mast cells (MMC). The
CTMC are stained with safranin and berberine sulfate,
have heparin in their granules, and have a relatively high
histamine content (approximately 10 pg/cell), whereas
the MMC do not react to these dyes, have predominantly
chondroitin sulfates in their granules, and have a
low histamine content (approximately 1 pg/cell).1,2 In
addition, CTMC degranulate in response to neurogenic
peptides such as substance P, vasoactive intestinal pep-
tide, and somatostatin, from 10-6 to 10-4 mol/L, whereas
MMC respond weakly or hardly at all to these peptides.:'
By culturing bone marrow cells in vitro with interleukin
(IL)-3 and IL-4, mast cells can be easily obtained in a pure
preparation (BMMC). These cells cause degranulation by
stimulation with IgE and antigen. They are thus thought to
be useful for investigating the biochemical events involved
in degranulation. These cells resemble MMC but are still
immature. They also differ from CTMC histochemically
and functionally. One remarkable difference in function
between BMMC and CTMC is responsiveness to neuro-
genic peptides. Bone marrow-derived mast cells fail
to react to neurogenic peptides, such as substance P,
whereas CTMC release significant amounts of histamine
in response to 10-5 rnol/L substance p'3 The mechanism of
this functional differentiation in mast cells is unclear.
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Several studies demonstrated that when the BMMC are
co-cultured with mouse skin-derived 3T3 fibroblasts, the
BMMC acquire biochemical characteristics resembling
CTMC; that is, the mast cells acquire the ability to be
stained with safranin, to increase histamine content, and
to synthesize hepcrin.v'' Fibroblasts thus playa key role in
the differentiation of mast cell precursors into CTMC.
Also of interest is the fact that a potent mast cell growth
factor, stem cell factor (SCF), has been identified in
fibroblasts, and is encoded in the SI locus and ligand for
the c-kit proto-oncogene product." Numerous studies
both in vitro and in vivo have shown the importance of
SCF in the development of mast cells."
In this study we demonstrated that mouse BMMC
acquire responsiveness to substance P by co-culture with
NIH/3T3 fibroblasts in the presence of soluble SCF, and
that this response of co-cultured mast cells is not due to
expression of a specific substance Preceptor, NK- 1.
MATERIALS AND METHODS
Animals
Six-week-old BALB/c and C57BL/6 male mice were pur-
chased from Nihon SLC (Hamamatsu, Japan). NC mice
were provided by Dr J Hayakawa, Institute for Experimental
Animals, School of Medicine, Kanazawa University, Japan.
Growth factors and chemicals
Mouse recombinant IL-3, mouse recombinant IL-4, and
mouse recombinant SCF were purchased from R&D
Systems Inc. (Minneapolis, MN, USA). Substance P and
human serum albumin (HSA)-conjugated dinitrophenol
(DNP) were purchased from Sigma Chemical Co. (St Louis,
MO, USA). Rat anti-DNP-lgE was purchased from Bio-
Source International (Camarillo, CA, USA).
Cell culture
NIH/3T3 fibroblast cell line was obtained from Dainip-
pon Pharmaceutical Co. Ltd (Osaka, Japan) and
cultured in a-minimal essential medium (aMEM)
(Dainippon) supplemented with 5% calf-serum, 2 mmol/L
glutamine, 100 IU/mL penicillin G and 100 /-lg/mL
streptomycin. Bone marrow-derived mast cells were
obtained by culturing bone marrow cells from 6-week-
old male mice as previously described." Briefly, bone
marrow cells were suspended at a density of 1 X 10 6
cells/mL in aMEM supplemented with 10% fetal calf-
serum (FCS), 50/-lmol/L 2-mercaptoethanol, 2
mrnol/L glutamine, 100 IU/mL penicillin G, 100
/-lg/mL streptomycin, 5 ng/mL IL-3, and 2 ng/mL IL-4.
The cell suspension was then transferred into a 25 ern?
culture flask and cultured for over 4 weeks by replacing
half of the medium with fresh medium each week. After
4 weeks, more than 98% of nonadherent cells were
stained positively with alcian blue.
Co-culture of BMMC and 313 fibroblasts
In this study 3T3 fibroblasts were suspended in 0.5 mL of
aMEM supplemented with 10% FCS, 2 rnrnol/L gluta-
mine, 100 IU/mL penicillin G, 100 uq/rnl, streptomycin
(complete aMEM) at a density of 6 X 10 4 cells/mL. A
total of 0.5 mL of suspension was seeded in each well of
the four-well multidishes (Nunclon Delta SI, Roskilde,
Denmark) and cultured until confluence was attained.
The BMMC suspension (3 X 104 cells) in complete
aMEM were seeded on the NIH/3T3 fibroblast mono-
layers and cultured in either the presence or absence of
growth factors. Half of the medium was replaced every
48 h during the culture. The number of mast cells in co-
culture after resuspension in aMEM by trypsinization was
calculated using the following formula: number of mast
cells/dish = A X C/B, where A is the total number of
cells in a culture dish, B the total number of cells in a cyto-
centrifuge specimen, and C the number of alcian blue-
positive cells in the same specimen.
Aldan blue/safranin staining of cultured cells
Cells suspended in 70 ul. of aMEM with 1% bovine serum
albumin were cytocentrifuged on glass slides, air dried, and
fixed in Carnoy's solution (30% chloroform, 10% acetic
acid in ethanol) for 20 min. The cells fixed on glass slides
were incubated with 0.5% alcian blue in 0.3% acetic acid
for 60 min, washed with water, and further incubated with
0.1 % safranin in 1% acetic acid for 5 min. After being
washed again with water, the cells were embedded in a
mounting reagent. Connective tissue-type mast cells from
the peritonea of normal mice were used as positive controls
for safranin staining.
Histamine release assay
Suspensions of BMMC were equilibrated at 3JOC for
5 min, and then incubated in 1.5 mL polypropylene test
tubes containing serially diluted substance P in complete
aMEM supplemented with 5 ng/mL IL-3 and 2 ng/mL
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IL-4 for 20 min. Substance P was dissolved in saline con-
taining 0.04% acetic acid at a concentration of 10-3mol/L
and stored at -80°C prior to use. Ion composition of
aMEM was Ca 2+ 1.8 mrnol/L, K+ 5.3 rnrnol/L, Mg2+
0.8 mrnol/L, Na+ 141 rnrnol/L, CI- 125 mrnol/L, S04 2-
0.8 rnrnol/L, CO/- 24 rnrnol/I and P043+ 1 rnrnol/L.
The final volume (0.5 mL) in each tube contained 2 X 105
cells. After centrifugation (4°C, 150g, 5 min), supernatants
were mixed with the same volume of 0.5 N perchloric
acid, vortexed, and centrifuged at 12 OOOg for 10 min to
precipitate the protein. Cell pellets in the test tubes were
resolved in 1 mL of 0.25 N perchloric acid to release
histamine.
Co-cultured cells were fed by 0.45 mL of fresh medium
and equilibrated at 3JOC for 5 min. Either a one-tenth
volume (0.05 mL) of serially diluted substance P solution
or medium alone was added to the co-culture, which was
further incubated for 20 min. Supernatants of the co-
cultures were transferred into 1.5 mL polypropylene test
tubes and centrifuged (4°C, 150g, 5 min) to precipitate
cell components. The supernatants were mixed with the
same volume of 0.5 N perchloric acid to precipitate the
protein. Both the cell pellets in the test tubes and the co-
cultured cells were resolved in 1 mL of 0.25 N perchloric
acid to release residual histamine.
In all experiments, histamine release was monitored by
stimulation with DNP and anti-DNP IgE to establish that
the mast cells were responsive to stimulation. Briefly, mast
cells were incubated with 0.5 uq/rnl, anti-DNP IgE over-
night and washed twice with medium before a series of
concentrations of HSA-DNP was added. After 30 min incu-
bation at 3JOC, histamine content was determined in the
supernatant and the cell pellets.
Histamine content in samples was determined by using
an automated histamine analyzer (Tosoh Corporation,
Osaka, Japan). Histamine release was expressed as a
percentage of the total cellular content of the histamine
as calculated by the formula:
histamine in supernatant/(histamine in pellet +
histamine in supernatant) X 100
Reverse transcriptase-mediated polymerase
chain reaction (RT-PCR)
Polyadenylated RNA was directly isolated from cells or from
brain tissue by using a FastTrack mRNA Isolation Kit (Invit-
rogen, San Diego, CA, USA). cDNA was synthesized from
0.1 Ilg of polyadenylated mRNA using a cDNA Cycle Kit
(Invitrogen) and analyzed by using a polymerase
chain reaction (PCR) as described previously? The primers
used were: mouse c-kit sense primer; 5'-GTCAGATGGA-
CTITCMGACC-3' (nucleotide position 218-238); mouse
c-kit antisense primer; 5'-CACTCCAGMTCGTCMCTCT-
3' (nucleotide position 878-898);10 mouse NK-l receptor
sense primer; 5'-AGGACAGTGA-CCMTIATTTCCTGG-
3' (nucleotide position 4-28); mouse NK-l receptor anti-
sense primer; 5'-CTGCTGGATGMCTTCTTMGGTAG-3'
(nucleotide position 645-669) .11 The reaction conditions
were denaturation at 94°C for 1 min, annealing at 55°C for
2 min, and extension at 72°C for 3 min over 35 cycles in a
DNA thermal cycler (Astec PC700, Fukuoka, Japan). The
PCR products (10 ul) were electrophoresed in 1.5% agar
gels in 1 X TAE buffer (40 rnrnol/l. Tris, 20 mmol/L acetic
acid, 2 mmol/L Na3 EDTA) at a constant 100 V for 2 h.
Products were visualized by ethidium bromide over a UV
transilluminator (CSF-20B, CosmoBio, Tokyo, Japan) and
photographed. Predicted sizes of PCR products were
681 bp for c-kit and 666 bp for NK-1 receptor.
Statistical analysis
Data were analyzed using the Mann-Whitney U-test. Results
were expressed as either the mean ± SD or mean ± SEM.
Probability (P) values less than 0.05 were considered to be
significant.
RESULTS
Co-culture of BMMC with 3T3 fibroblasts
By culturing bone marrow cells with a combination of
5 ng/mL IL-3 and 2 ng/mL IL-4 for 4 weeks, a virtually
pure mast cell preparation (BMMC) was available
in three different strains: NC, BALB/c, and C57BL/6.
Histamine content of these BMMC varied as indicated
in Table 1.
When 3 X 104 BMMC were co-cultured with mouse
3T3 fibroblasts in complete aMEM, only approximately
50% of the initially seeded BMMC were still present after
1 week, 30% after 2 weeks, and 10% after 3 weeks. In
contrast to this progressive loss of mast cells, when co-
cultured with mouse 3T3 fibroblasts in the presence of
SCF the growth of BMMC was enhanced in a dose-
dependent manner, and the growth reached a plateau
above 10 ng/mL of SCF (data not shown). With 10 ng/mL
of SCF, the number of mast cells more than doubled in
the first week, but thereafter decreased gradually. After
3 weeks of co-culture in the presence of 10 ng/mL SCF, the
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Co-cultured mast cells**
Safranin Histamine
(%) (pg/cell)
-----'----
31 ± 5 7.4 ± 4.7 (n = 6)
10 ± 3 4.3 ± 1.6 (n = 4)
7 ± 2 3.3 ± 2.0 (n = 4)
(n = 14)
(n = 6)
(n = 8)
Histamine
(pg/cell)
Mouse Safranin
type (%)
------------ ---'------
NC 0 ± 0*** 0.67 ± 0.35
BALB/c 0 ± 0 0.04 ± 0.04
C57BL/6 0 ± 0 0.09 ± 0.12
------~
Table 1. Staining and histamine content of mast cells
BMMC*
*Bone marrow-derived mast cells (BMMC) were obtained by culturing bone marrow cells in the presence of 5 ng/mL IL-3 and 2 ng/mL IL-4 for
4 to 8 weeks.
**Co-cultured mast cells were obtained by culturing BMMC further with NIH/3T3 fibroblasts in the presence of 10 ng/mL stem cell factor (SCF) for
3 weeks.
***Values are mean ± SD.
number of mast cells per well was 5.0 ± 1.5 X 104 in NC,
4.0 ± 2.3 X 104 in BALB/c, and 3.8 ± 1.1 X 104 in
C57BL/6 (n = 4, mean ± SO in each case). Compared
with the initial value, the amount of histamine per cell
increased significantly during co-culture in the presence of
10 ng/mL SCF (Table 1). After 3 weeks, the histamine
content of co-cultured mast cells was enhanced consider-
ably more than that of BMMC kept in suspension culture
with IL-3 and IL-4. Bone marrow-derived mast cells were
not stained by safranin at all, whereas 10-30% of the mast
cells became safranin-positive when co-cultured with 3T3
fibroblasts in the presence of 10 ng/mL SCF (Table 1).
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Substance P-induced histamine release from
mast cells
Bone marrow-derived mast cells did not secrete hista-
mine when exposed to substance P in a range from 10-7
to 10-5 rnol/L among the three different strains of mice
(NC, BALB/c and C57BL/6), although these cells relea-
sed up to 50% of total histamine when stimulated by
10-1000 ng/mL HSA-ONP after being sensitized by anti-
ONP IgE antibody. When BMMC were maintained with
100 ng/mL SCF in suspension culture for 3 weeks, no
remarkable response was observed to 10-7 to 10-5 rnol/L
of substance P (data not shown). Bone marrow-derived
mast cells co-cultured with 3T3 fibroblasts in the absence
of additional growth factors decreased in number;
3 weeks later only approximately 10% of the mast cells
survived. These mast cells still contained low amounts of
histamine, but did not respond to substance P. However,
they began to respond to substance P 1 week after being
placed in co-culture with 3T3 fibroblasts in the presence
of 10 ng/mL SCF (Fig. 1). By 3 weeks, co-cultured mast
cells released approximately 20% of total histamine when
exposed to 10-5 rnol/L substance P (Fig. 1). Histamine
Fig. 1 Histamine release with substance P in co-cultured mast
cells. Bone marrow-derived mast cells from three different
strains of mice (NC, .; BALB/c, ~; and C57BL/6, 0) were co-
cultured with NIH/3T3 fibroblasts in the presence of 10 ng/mL
stem cell factor and incubated with 10-5 rnol/L substance P
for 20 min. Percentspontaneous release in the absence of sub-
stance P was subtracted from measured release. Results are
from four experiments performed in duplicate and are expressed
as mean ± SD.
was released in a dose-dependent manner in a range
from 10-7 to 10-5 rnol/L (Fig. 20). In contrast, BMMC
grown by themselves did not show any response to
substance P in concentrations up to 10-5 mol/l.. This unres-
ponsiveness of mast cells was constant during the sus-
pension culture with 5 ng/mL IL-3 and 2 ng/mL IL-4 for
up to 6 months (data not shown). When activated with
HSA-ONP after sensitization with 0.5 Ilg/mL IgE, both
BMMC and co-cultured mast cells released significant
amounts of histamine in similar dose-dependent manners
(Fig. 2b). Although percentage histamine release was
found to be similar in BMMC and co-cultured mast cells,
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the abso lute amo unts of histam ine released were much
greater in co -cultured most cells because the histamine
con tent of co -cu ltured mast cells was 10 to l OO-fo ld
grea ter tha n thot of BMMC. The results obta ined with co-
cultured mast cells were similar fo r each of the three
different strains of mice (Fig. 3).
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NK- 1 receptor mRNA expression
Since the NK-1 receptor recognizes substance P, we
examined NK- 1 receptor mRNA expression in BMMC and
co-cultured mast cells by the RT-PCR technique. Analysis
of PCR amplification with specific primers for the NK- 1
receptor gene failed to show mRNA expression for the
NK- 1 receptor in either BMMC or co-cultured mast cells
in the presence of 10 ng/mL SCF (Fig. 4).
DISCUSSION
Substance P is a member of the tachykinin family and
resides in primary sensory cutaneous neurones, both in
dorsal root ganglia and in distal nerve terminals. Anti-
dromic stimulation causes substance P to be released
from nerve terminals, resulting in a wheal and flare reac-
tion. In this reaction, histamine released from skin mast
cells by stimulation with substance P is considered to play
a crucial role, because pretreatment with H- 1 antagonists
markedly reduces the magnitude of the reaction induced
by substance p'12,13 and substance P induces histamine
release in rat peritoneal mast cells and in human cuta-
neous mast cells. 3, 14, 15
Bone marrow-derived mast cells differ from CTMC func-
tionally in that they are unresponsive to neurogenic
peptides. Our results indicate that fibroblasts playa key role
in the functional differentiation of BMMC into CTMC. When
BMMC were co-cultured with 3T3 fibroblasts in the pres-
ence of 10 ng/mL SCF, BMMC increased in both number
and histamine content per cell. One week later these co-
cultured mast cells gained responsiveness to substance P,
and this response was strengthened during co-culture
(Fig. 1). It is unlikely that this functional phenotypic change
was due to stimulation by SCF alone, because BMMC
maintained with up to 100 ng/mL soluble SCF exhibited no
response to substance P. Bone marrow-derived mast cells
co-cultured with 3T3 fibroblasts in the absence of additional
growth factors still contained low amounts of histamine, but
did not respond to substance P. Although fibroblasts are a
known source of SCF, the amount of SCF expressed on
NIH/3T3 fibroblasts appears to be insufficient for a pheno-
typic change of mast cells. These results suggest that a
combination of a sufficient amount of SCF with some other
factor from fibroblasts is responsible for the phenotypic
change of BMMC into CTMC.
We learned of studies in which BMMC acquired respon-
siveness to compound 48/80 or substance P after co-
culture with Swiss 3T3 fibroblasts in combination with
WEHI-3 conditioned medium 16 or a high amount of SCF.17
In addition, Ogasawara et a/. demonstrated experimen-
tally that a labile soluble substance other than SCF is
involved in the mast cell/fibroblast interaction. 17 The mech-
anism underlying this phenotypic change still remains to be
determined.
The mechanism for substance P-induced degranulation
in mast cells is also obscure. Substance P binds preferen-
tially to a G-protein-coupled neurokinin- 1 (NK- 1) recep-
tor and is involved in various biological functions, such as
pain transmission and smooth muscle controction.l'v'? In
a mast cell line CFTL 12, which responds to substance P
(10-9 to 10-7 mol/I) to release tumor necrosis factor-a,
substance Preceptor mRNA is constitutively detected by
Northern blotting.2o However, the existence of NK recep-
tors on mast cells has been questioned. 14,21,22 The effective
concentrations of substance P to trigger histamine release
in CTMC (10-7 to 10-5 mol/I) are well above those re-
quired to stimulate neurokinin receptors (10-9 moIlL}.14,15
In addition, examination using Arg-Pro-Lys-Pro(CH2}11CH3
has revealed that the N-terminal basic amino acid resi-
dues (Arg, Lys) are essential for histamine releasing activity
and that interaction between the C-terminal sequence of
substance P and mast cells is non-specific and dependent
only upon the hydrophobic nature of that part of the
peptide,23 while C-terminal tachykinin consensus residues
(Phe-X-Gly-Leu-Met-NH3) are essential for binding to NK
receptors." suggesting uninvolvement of the NK- 1 recep-
tor in substance P-induced mast cell activation. This was
supported by our results, which indicated that concen-
trations of substance P to induce histamine release in
co-cultured mast cells were comparable to those needed
to activate CTMC, and that NK-1 receptor mRNA was
not detected in either BMMC or co-cultured mast cells
upon application of the RT-PCR technique. In substance
P-induced mast cell activation a direct activation model
of G-proteins has been proposed.21,22,25 Hydrophobic
C-terminal residues of substance P are considered to
penetrate the membrane to activate membrane-coupled
G-proteins in a receptor-independent manner, resulting in
histamine release. However, the effective dose of sub-
stance P to activate G-proteins (10-5 to 10-3 rnol/I) is
much higher than that required for mast cell octivoticn.i"
The fact that neuraminidase treatment induces the desen-
sitization of mast cells to substance Psuggests that negative
charges of sialic acid residues facilitate the action of
substance P. Another substance P receptor with low
affinity, although not yet identified, might be involved in
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the activation of CTMC. Mast cell activation by substance
P is not likely to be mediated through the NK-2 receptor,
which shows 10 to 1OO-fold lower affinity for substance P
than neurokinin A, because neurokinin A, a high affinity-
agonist to the NK-2 receptor, does not stimulate mast cell
degranulation. Nor have we detected NK-2 receptor
mRNA in cocultured mast cells or BMMC by RT-PCR (data
not shown). A difference in Co ' ' concentration in the
reaction solution was also unlikely to have affected the
responsiveness of co-cultured BMMC, because the Ca 2+
concentration in the reaction was kept constant in the
medium, somewhat below physiological condition through-
out the experiments.
In this study we have achieved a functional differentia-
tion of BMMC into cells strongly resembling CTMC by
co-culture with NIH/3T3 fibroblasts in the presence of
lower concentration of SCF, presumably resembling the
micro-environment of dermis in skin. Our results imply
that this functional phenotypic change of mast cells is
seen in general for mice, because BMMC obtained from
three different strains of mice (NC, BALB/c and C57BL/6)
acquired responsiveness to substance P after co-culture
with 3T3 fibroblasts in the presence of SCF. Our results
also imply that the response to substance Pof co-cultured
BMMC is not through the NK-l receptor.
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